Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
Amyotrophic lateral sclerosis (ALS), a fatal neurodegenerative disease, affects motor neurons, causing progressive muscle atrophy and weakness. Current treatments are ineffective, with most patients dying within 3-5 years of diagnosis. The disease's exact cause is unclear, but factors such as oxidative stress and protein abnormalities are implicated. Abnormal protein deposits and neurotoxic factors in the brain and spinal cord contribute to ALS pathology. Recent research on the brain's glymphatic-lymphatic system suggests impaired waste clearance may exacerbate ALS. Restoring drainage connections between cervical lymphatic vessels and veins could potentially alleviate neurodegenerative disease progression.
Official title: Evaluation of the Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in Patients With Amyotrophic Lateral Sclerosis
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
OBSERVATIONAL
Enrollment
3
Start Date
2024-08-01
Completion Date
2027-08-01
Last Updated
2024-05-16
Healthy Volunteers
No
Conditions
Interventions
Deep cervical lymph node-vein bypass surgery
Deep cervical lymph node-vein bypass surgery, connecting deep cervical lymph node input lymphatic vessel